These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10513630)

  • 1. Repression of acyl-CoA:cholesterol acyltransferase by a traditional herbal medicine (Kampo medicine), Ogi-Keishi-Gomotsu-To-Ka-Kojin.
    Wu CZ; Inoue M; Ogihara Y
    Biol Pharm Bull; 1999 Sep; 22(9):994-6. PubMed ID: 10513630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypercholesterolemic action of a traditional Chinese medicine (Kampo medicine), Ogi-Keishi-Gomotsu-To-Ka-Kojin.
    Wu CZ; Inoue M; Ogihara Y
    Biol Pharm Bull; 1998 Dec; 21(12):1311-6. PubMed ID: 9881645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihyperlipidemic action of a Traditional Chinese Medicine (kampo medicine), Ogi-Keishi-Gomotsu-To-Ka-Kojin.
    Wu CZ; Inoue M; Ogihara Y
    Phytomedicine; 1997 Dec; 4(4):295-300. PubMed ID: 23195577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihyperlipidemic action of Ogi-Keishi-Gomotsu-To-Ka-Kojin against cyclophosphamide-induced hyperlipidemia in rabbits.
    Inoue M; Wu CZ; Ogihara Y
    Biol Pharm Bull; 1999 May; 22(5):486-90. PubMed ID: 10375169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of F 12511, (S)-2',3', 5'-trimethyl-4'-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor.
    Junquero D; Oms P; Carilla-Durand E; Autin J; Tarayre J; Degryse A; Patoiseau J; Colpaert FC; Delhon A
    Biochem Pharmacol; 2001 Jan; 61(1):97-108. PubMed ID: 11137714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma cholesterol reducing effect of FR129169, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in the rat.
    Sakuma Y; Hagihara H; Ohne K; Nagayoshi A; Mutoh S; Ito Y; Notsu Y; Okuhara M
    Jpn J Pharmacol; 1996 Jan; 70(1):35-41. PubMed ID: 8822087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters.
    Sugiyama Y; Ishikawa E; Odaka H; Miki N; Tawada H; Ikeda H
    Atherosclerosis; 1995 Feb; 113(1):71-8. PubMed ID: 7755657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acyl-coenzyme A:cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis.
    Miyazaki A; Sakai M; Sakamoto Y; Horiuchi S
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1095-9. PubMed ID: 14582454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure.
    Liang K; Vaziri ND
    Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E676-81. PubMed ID: 12217884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between bioavailability and hypocholesterolemic activity of YM17E, an inhibitor of ACAT, in cholesterol-fed rats.
    Uchida T; Aoyama K; Watanabe T; Higuchi S
    Atherosclerosis; 1998 Mar; 137(1):97-106. PubMed ID: 9568741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of a direct effect on hepatic acyl CoA: cholesterol acyl transferase (ACAT) activity by an orally administered enzyme inhibitor in the hamster.
    Burrier RE; Deren S; McGregor DG; Hoos LM; Smith AA; Davis HR
    Biochem Pharmacol; 1994 Apr; 47(9):1545-51. PubMed ID: 8185666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of exogenous cholesterol in diabetic rats: effects of treatment with insulin or with an acyl-CoA:cholesterol acyltransferase inhibitor.
    Maechler P; Wollheim CB; Bentzen CL; Niesor E
    Ann Nutr Metab; 1993; 37(4):199-209. PubMed ID: 8215237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of SMP-500, a novel acyl-coA:cholesterol acyltransferase inhibitor, on the cholesterol esterification and its hypocholesterolemic properties.
    Ioriya K; Noguchi T; Muraoka M; Fujita K; Shimizu H; Ohashi N
    Pharmacology; 2002 May; 65(1):18-25. PubMed ID: 11901297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide and structurally related tetrazole amide derivatives.
    O'Brien PM; Sliskovic DR; Picard JA; Lee HT; Purchase CF; Roth BD; White AD; Anderson M; Mueller SB; Bocan T; Bousley R; Hamelehle KL; Homan R; Lee P; Krause BR; Reindel JF; Stanfield RL; Turluck D
    J Med Chem; 1996 Jun; 39(12):2354-66. PubMed ID: 8691430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of the microsomal acyl-CoA: cholesterol acyltransferase by high-cholesterol diets in rabbit liver and small intestine.
    Sano M; Senjo M; Ishibashi T; Imai Y
    Hokkaido Igaku Zasshi; 1985 Nov; 60(6):893-7. PubMed ID: 4085969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACAT inhibitor HL-004 accelerates the regression of hypercholesterolemia in stroke-prone spontaneously hypertensive rats (SHRSP): stimulation of bile acid production by HL-004.
    Murakami S; Yamagishi I; Sato M; Tomisawa K; Nara Y; Yamori Y
    Atherosclerosis; 1997 Aug; 133(1):97-104. PubMed ID: 9258412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypolipidemic and antioxidant activity of the novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor KY-455 in rabbits and hamsters.
    Nakamura S; Kamiya S; Shirahase H; Kanda M; Yoshimi A; Tarumi T; Kurahashi K
    Arzneimittelforschung; 2004; 54(2):102-8. PubMed ID: 15038459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet.
    Junquero D; Bruniquel F; N'Guyen X; Autin JM; Patoiseau JF; Degryse AD; Colpaert FC; Delhon A
    Atherosclerosis; 2001 Mar; 155(1):131-42. PubMed ID: 11223434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypolipidemic action of F-1394, an acyl-CoA: cholesterol acyltransferase (ACAT) inhibitor, in high-fat diet fed beagle dogs].
    Kusunoki J; Aragane K; Kitamine T; Yamaura T; Ohnishi H
    Yakugaku Zasshi; 1997 Apr; 117(4):233-41. PubMed ID: 9167444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective inhibitor of intestinal ACAT, EAB309 suppresses both intestinal and hepatic cholesterol output and stimulates chylomicron removal.
    Umeda Y; Hirano T; Kako Y; Kamagata K; Okuyama K; Suzuki K
    Life Sci; 1998; 63(13):PL187-95. PubMed ID: 9763214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.